Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D.

MLA

La Sala, Lucia, et al. “Circulating MicroRNA-21 Is an Early Predictor of ROS-Mediated Damage in Subjects with High Risk of Developing Diabetes and in Drug-Naïve T2D.” Cardiovascular Diabetology, vol. 18, no. 1, Feb. 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1186/s12933-019-0824-2.

APA

La Sala, L., Mrakic-Sposta, S., Tagliabue, E., Prattichizzo, F., Micheloni, S., Sangalli, E., Specchia, C., Uccellatore, A. C., Lupini, S., Spinetti, G., de Candia, P., & Ceriello, A. (2019). Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D. Cardiovascular Diabetology, 18(1), N.PAG. https://doi.org/10.1186/s12933-019-0824-2

Chicago

La Sala, Lucia, Simona Mrakic-Sposta, Elena Tagliabue, Francesco Prattichizzo, Stefano Micheloni, Elena Sangalli, Claudia Specchia, et al. 2019. “Circulating MicroRNA-21 Is an Early Predictor of ROS-Mediated Damage in Subjects with High Risk of Developing Diabetes and in Drug-Naïve T2D.” Cardiovascular Diabetology 18 (1): N.PAG. doi:10.1186/s12933-019-0824-2.